Amgen Adds $300 Million to Puerto Rico Biologics Facility as U.S. Manufacturing Footprint Expands
Amgen announced an extra $300 million investment to expand its biologics manufacturing operations in Juncos, Puerto Rico, reinforcing its U.S. production footprint. The move supplements earlier commitments in Puerto Rico and other U.S. states and comes as U.S. policy could impose steep tariffs on imported branded pharmaceuticals unless manufacturer…